| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
|
| | Pam2CSK4 Basic information |
| Product Name: | Pam2CSK4 | | Synonyms: | Pam2CSK4;L-Lysine, S-[(2R)-2,3-bis[(1-oxohexadecyl)oxy]propyl]-L-cysteinyl-L-seryl-L-lysyl-L-lysyl-L-lysyl- | | CAS: | 868247-72-7 | | MF: | C65H126N10O12S | | MW: | 1271.82 | | EINECS: | | | Product Categories: | | | Mol File: | 868247-72-7.mol |  |
| | Pam2CSK4 Chemical Properties |
| Boiling point | 1302.9±65.0 °C(Predicted) | | density | 1.091±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble to 1 mg/ml in 0.25% acetic acid | | form | Powder | | pka | 3.27±0.10(Predicted) | | color | White | | Sequence | {(2R)-2,3-Bis(1-oxohexadecyl)oxy]propyl}-Cys-Ser-Lys-Lys-Lys-Lys |
| | Pam2CSK4 Usage And Synthesis |
| Uses | Pam2CSK4, a lipopeptide, is a TLR6-independent TLR2 ligand and agonist. Pam2CSK4 promotes platelet aggregation, and increases platelet adhesion to collagen-coated surfaces in a TLR2/NF-κB/BTK-dependent manner. Pam2CSK4 also activates iNOS expression and NO production in mouse macrophages[1][2][3]. | | storage | -20°C | | References | [1] Parra-Izquierdo I, et al. The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton's Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell Interactions. Front Immunol. 2021 Aug 30;12:729951. DOI:10.3389/fimmu.2021.729951
[2] Kulsantiwong P, et al. Pam2CSK4 and Pam3CSK4 induce iNOS expression via TBK1 and MyD88 molecules in mouse macrophage cell line RAW264.7. Inflamm Res. 2017 Oct;66(10):843-853. DOI:10.1007/s00011-017-1063-1
[3] Kaur A, et al. An efficient and scalable synthesis of potent TLR2 agonistic PAM2CSK4. RSC Adv. 2018 Mar 5;8(18):9587-9596. DOI:10.1039/c8ra01387j |
| | Pam2CSK4 Preparation Products And Raw materials |
|